Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;40(2):474-488.
doi: 10.1007/s12325-022-02364-2. Epub 2022 Nov 12.

Burden of Fatigue Among Patients with Ulcerative Colitis and Crohn's Disease: Results from a Global Survey of Patients and Gastroenterologists

Miguel Regueiro  1 , Theresa Hunter  2 , Rina Lukanova  3 , Mingyang Shan  4 , Rosie Wild  3 , Hannah Knight  3 , Priyanka Bannikoppa  4 , April N Naegeli  4
Affiliations

Burden of Fatigue Among Patients with Ulcerative Colitis and Crohn's Disease: Results from a Global Survey of Patients and Gastroenterologists

Miguel Regueiro et al. Adv Ther. 2023 Feb.

Abstract

Introduction: To assess the prevalence of fatigue and its association with disease activity and patient-reported outcomes among patients with ulcerative colitis (UC) or Crohn's disease (CD).

Methods: Data from a cross-sectional survey conducted with gastroenterologists and their consulting adult patients with UC or CD were analyzed. Data were collected via gastroenterologist-completed patient record forms and patient-self completion forms. Patient demographics, clinical characteristics, disease activity and medication use were reported by the gastroenterologist, while current symptoms (fatigue, rectal urgency, abdominal pain, sleep disturbance), work productivity and the Short Inflammatory Bowel Disease Questionnaire (SIBDQ) were reported by the patient. Logistic regression models were used to identify measures associated with fatigue and expressed as odds ratio (OR) with 95% confidence interval. p < 0.05 was considered statistically significant.

Results: A total of 1057 patients with UC and 1228 patients with CD were included in this analysis. Fatigue was reported in 22.6% of UC and 26.0% of patients with CD. Higher proportion of patients with UC and fatigue had moderate/severe disease activity (p = 0.0001), had a higher Mayo score (5.0 vs. 4.0, p < 0.0001) and were unemployed (5.6% vs. 3.9%, p = 0.0149) compared to those without fatigue. In patients with CD reporting fatigue, a higher proportion were female (55.9% vs. 48.2%, p = 0.0193), were unemployed (5.8% vs. 4.9%, p = 0.0069), had moderate/severe disease (p < 0.0001) and had a higher mean Crohn's Disease Activity Index score (145.0 vs. 96.2, p < 0.0001) than patients without fatigue. Patients with UC and fatigue had higher mean level of pain (p < 0.0001) and sleep disturbance (p < 0.0001), whereas patients with CD and fatigue had lower SIBDQ scores (p < 0.0001) and greater work impairment (p = 0.0015) than patients without fatigue. Abdominal pain (OR: 2.01, p = 0.001) and use of immunomodulators (OR: 1.69, p = 0.006) increased the odds of having fatigue in patients with UC. In patients with CD, abdominal pain (OR: 2.29, p < 0.001) and use of biologics or biosimilars (OR: 2.02, p = 0.003) increased the odds of having fatigue.

Conclusion: Fatigue is a common symptom among patients with UC or CD that is associated with higher levels of disease activity and decreased work productivity and is driven by various factors. A multidisciplinary approach may be needed to manage fatigue.

Keywords: Crohn’s disease; Fatigue; Quality of life; Ulcerative colitis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Factors associated with fatigue among patients with ulcerative colitis. *p < 0.05. 5-ASA 5-aminosalicylic acid, BMI body mass index, RB rectal bleeding, SF stool frequency, SIBDQ short inflammatory bowel disease questionnaire
Fig. 2
Fig. 2
Factors associated with fatigue among patients with Crohn’s disease. *p < 0.05. 5-ASA 5-aminosalicylic acid, BMI body mass index, CDAI Crohn’s Disease Activity Index; SIBDQ short inflammatory bowel disease questionnaire
See this image and copyright information in PMC

References

    1. Bączyk G, Kozłowska KA, Formanowicz D, Białas E, Karoń J, Krokowicz P. The relationship between the symptom of fatigue and the functioning of patients with inflammatory bowel diseases after surgery. Prz Gastroenterol. 2019;14(4):242–249. - PMC - PubMed
    1. Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012;6(10):965–990. doi: 10.1016/j.crohns.2012.09.003. - DOI - PubMed
    1. Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis. 2010;4(1):7–27. doi: 10.1016/j.crohns.2009.12.003. - DOI - PubMed
    1. Römkens TE, van Vugt-van Pinxteren MW, Nagengast FM, van Oijen MG, de Jong DJ. High prevalence of fatigue in inflammatory bowel disease: a case control study. J Crohns Colitis. 2011;5(4):332–337. doi: 10.1016/j.crohns.2011.02.008. - DOI - PubMed
    1. Barsevick AM, Cleeland CS, Manning DC, O'Mara AM, Reeve BB, Scott JA, et al. ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage. 2010;39(6):1086–1099. doi: 10.1016/j.jpainsymman.2010.02.006. - DOI - PMC - PubMed

Publication types

Substances